O ne characteristic in the early development of atherosclerotic lesions is the formation of foam cells. 1 The conversion of macrophages into foam cells cannot be provoked by native low density lipoprotein (LDL). 2 Various modifications of LDL, such as acetylation, acetoacetylation, malondialdehyde treatment, and oxidative modification, lead to LDL uptake via scavenger receptors, which leads to foam cell formation. 3 Evidence has recently been provided that various classes of scavenger receptors are involved in the uptake of modified LDL by peritoneal mouse macrophages. 4 -5 Also, in rat liver it has been established that different recognition sites are involved in the uptake of differently modified LDL. 6 When injected into rats, both acetylated LDL (Ac-LDL) and oxidatively modified LDL (Ox-LDL) are rapidly cleared from the blood circulation by the liver. Separation of the liver into parenchymal cells, endothelial cells, and Kupffer cells indicated that endothelial cells were mainly responsible for the uptake of Ac-LDL, whereas Kupffer cells were responsible for the uptake of most of the Ox-LDL. In vitro studies with isolated liver cells provided further evidence that various scavenger receptors are involved in the liver uptake of modified LDL. In addition to the Ac-LDL receptor on liver endothelial cells, 7 -8 which interacts with both Ac-LDL and Ox-LDL, a specific recognition site for Ox-LDL that was highly concentrated on Kupffer cells was reported. 6 Because several lines of evidence suggest that oxidative modification can occur in vivo 1 - 910 and because Ox-LDL, when injected into rats, is rapidly cleared from the circulation by the liver, it was suggested that in vivo Kupffer cells will form the major protection system against the occurrence of atherogenic Ox-LDL particles in the blood.
However, the relevance of these studies for humans is unclear especially because it was reported that human hepatocytes express no surface receptors for modified LDL, 11 although Edge et al 12 found that modified LDL was bound and degraded by hepatocytes at 30-50% of the level of native LDL. Kume et al 13 indicated that human endothelial cells, in contrast to mouse peritoneal macrophages, do not have any additional receptors specific only for Ox-LDL. In earlier studies we found that both human parenchymal and Kupffer cells interact with LDL through the classic LDL receptor, 14 although the association of LDL with Kupffer cells is more efficiently coupled to degradation than with parenchymal cells. The availability of cultured human liver parenchymal cells and human Kupffer cells enabled us to compare directly the interaction of Ac-LDL and Ox-LDL with human liver cells.
Methods

Materials
Collagenase type I, human serum albumin (fraction V), dexamethasone, and chloroquine were purchased from Sigma Chemical Co. (St. Louis, Mo.); Nycodenz was obtained from Nycomed A/S (Oslo, Norway); and 125 I was purchased from Amersham International (Amersham, Bucks, UK). Fetal calf serum, penicillin, and streptomycin were obtained from Boehringer (Mannheim, Germany), and Williams' E culture medium and kanamycin were purchased from Flow Laboratories (Irvine, Scotland, UK). RPMI-1640 cell culture medium was from GIBCO (Paisley, Scotland, UK), and multiwell cell culture dishes were from Costar (Cambridge, Mass.). All other chemicals were of analytical grade.
Isolation, Iodination, Oxidation, and Acetylation of LDL
Human LDL was obtained from the blood of healthy volunteers who had fasted overnight. Isolation of LDL (1.024<d< 1.055 g/ml) was performed according to the procedure of Redgrave et al 15 and was followed by a second identical centrifugation. LDL was acetylated by repeated additions of acetic anhydride as described earlier. 16 LDL was oxidized by exposure to copper sulfate in phosphate-buffered saline at 37°C during a 20-hour incubation period according to the procedure of Steinbrecher et al, 17 as described in Reference 6. Before oxidation LDL was dialyzed extensively at 4°C against phosphate-buffered saline containing 10 fiM EDTA. LDL was oxidized by exposure of 200 fig apolipoprotein/ml to copper sulfate (5 /AM free Cu 2+ concentration) in phosphate-buffered saline at 37°C for 20 hours. Oxidation was stopped by refrigeration and the addition of 200 fiM EDTA. Control incubations were performed in the presence of 200 ^tM EDTA without copper sulfate. Chemical and physical properties of oxidized LDL were identical to those reported earlier. 6 On 0.75% agarose gel electrophoresis the oxidized LDL showed an increased relative electrophoretic mobility compared with native LDL. The R, value of LDL oxidized for 20 hours was 0.55±0.01 (n = 6, mean±SEM 19 
Isolation and Culturing of Human Liver Cells
Human liver cells were isolated from livers obtained through the Auxiliary Liver Transplantation Program at the University Hospital Dijkzigt in Rotterdam, The Netherlands. Permission was given by the Medical Ethics Committee to use the part of the donor liver remaining after transplantation for scientific research. The livers were obtained from physically healthy organ donors who died after brain hemorrhage or severe traumatic brain injury. During resection of the left lobe, the liver was perfused by portal vein cannulation with Euro-Collins (4°C).
After resection the left liver lobe was transported to the perfusion site within 45 minutes in cold buffer (4°C) containing 10 mM N-2-hydroxyethylpiperazine-Af'-2-ethanesulfonic acid (HEPES), 142 mM NaCl, 6.7 mM KC1, and 0.5 mM ethylene glycol-bisO-aminoethyl ether)-A',A',Ar',Ar-tetraacetic acid (EGTA, pH 7.4). Human parenchymal liver cells were isolated as described earlier. 20 Kupffer cells were isolated by centrifugal elutriation and characterized as reported in detail earlier. 14 The parenchymal cells were cultured in 12-well plastic culture dishes (22-mm diameter) at 0.5 xlO 6 cells per well in Williams' E medium, supplemented with 10% heat-inactivated fetal calf serum, 2 mM L-glutamine, 2 milliunits/ml insulin, 1 mM dexamethasone, 100 units/ml penicillin, 100 /xg/ml streptomycin, and 50 /ig/ml kanamycin at 37°C in a humidified 5% CO 2 /95% air atmosphere. The medium was renewed 6-12 hours after seeding and every 24 hours thereafter. Directly after isolation the viability of the parenchymal cells, which was examined by a trypan blue exclusion test, was 70.2±10.8% (n=5). Experiments with cultured parenchymal cells were performed between the second and the sixth day after seeding of the cells. At this stage, the purity of the cells was 99%, as determined by phase-contrast microscopy, and the viability of the cells was >95%. Human Kupffer cells were plated in twowell cluster plates at a density of 1 x 10 6 cells per well in RPMI-1640 medium supplemented with 10% (vol/vol) heat-inactivated fetal calf serum, 2 mM L-glutamine, 100 units/ml penicillin, and 100 jig/ml streptomycin at 37°C in a humidified 5% CO 2 /95% air atmosphere. The viability of the Kupffer cells after isolation was >95%. The purity of Kupffer cells in culture as examined by electron microscopy was >70%.
14 Other cell types present in the Kupffer cell cultures were mostly white blood cells and occasional parenchymal cells, liver endothelial cells, or fat storage cells. The parenchymal cells used in this study were nondividing cells able to accumulate taurocholic acid intracellularry to the same extent as cultured rat hepatocytes. 21 Cultured human parenchymal cells could synthesize and secrete very low density Upoprotein (VLDL), LDL, high density lipoprotein (HDL) (with VLDL as the major species, namely 68 ±9%), apolipoprotein (apo) B, apo A-I, apo A-II, apo E, apo C-II, 22 albumin, and plasminogen inhibitor. 23 Also, the transport and metabolism of thyroid hormones were qualitatively comparable with these processes in rat hepatocytes, 24 and the cells expressed a specific high-affinity site for HDL. 25 Furthermore, with both 
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FIGURE 1. Line plots comparing the cell association and degradation capacity ofacetylated (Ac) low density Upoprotein (LDL) or oxidized (Ox) LDL by human parenchymal cells (PC) and Kupffer cells (KC) in culture. Amount of 12S I-Ac-LDL (panels A and B) or l25 I-Ox-LDL (panels C and D) was varied, and the cell association or degradation after a 3-hour incubation at 37°C is expressed as nanograms of apolipoproteins per milligram of cell protein.
human parenchymal liver cells and human Kupffer cells, association and degradation of LDL proceeds through the specific LDL receptor, 14 whereas the LDL receptor on parenchymal cells is subject to downregulation by LDL and /3-VLDL. 26 
Cell Association and Degradation of Lipoproteins by Human Liver Cells
At 24 hours before the start of the experiment, the culture medium was removed and replaced by medium containing 1% (wt/vol) human serum albumin. Incubations were performed in medium containing 1% (wt/vol) human serum albumin and the indicated amounts of I-lipoproteins and other additions. Cells were incubated for 3 hours at 37°C to determine cell association and degradation. After incubation culture plates were placed on ice, and 0.5 ml of the medium was taken to measure the degradation of ^I-lipoprotein as described earlier. 27 The cells were washed five times with ice-cold buffer containing 0.15 M NaCl, 50 mM tris(hydroxymethyl)aminomethane (Tris) hydrochloride, 2.5 mM CaCl 2 (pH 7.4), and 0.2% bovine serum albumin, and then twice more with the same buffer without bovine serum albumin. Cells were then dissolved in 0.1N NaOH, and cell-associated radioactivity was determined. Protein content was measured according to the procedure of Lowry et al. 28 Results
Uptake and Degradation of I25 I-Ac-LDL and l25 I-Ox-LDL by Human Liver Parenchymal Cells and Kupffer Cells
A direct comparison of the total capacity of cell association and degradation for Ac-LDL and Ox-LDL of human parenchymal and Kupffer cells is shown in Figure 1 association with Kupffer cells (approximately nine times higher than for Ac-LDL) leads during 3 hours of incubation to a degradation of Ox-LDL that is 2.3-fold higher than for Ac-LDL. These data indicate that the total amount of Ox-LDL handled by human Kupffer cells (cell association and degradation) is fivefold higher than that of Ac-LDL.
The kinetics of cell association and degradation of Ac-LDL and Ox-LDL by Kupffer cells are illustrated in Figure 2 . When the interaction of I25 I-Ac-LDL in the presence of excess unlabeled Ac-LDL is subtracted from the total cell association or degradation, the saturable association and degradation of 125 I-Ac-LDL by Kupffer cells is evident. The maximum level of high-affinity association of 125 I-Ac-LDL by Kupffer cells at 3 hours of incubation is 290 ng apolipoprotein/mg cell protein while the degradation reaches a value of 600 ng apolipoprotein/mg cell protein (half maximum at approximately 5-10 /ig/ml Ac-LDL). The association and degradation of l25 I-Ox-LDL appeared saturable as well, although the so-called nonspecific component (in the presence of excess unlabeled Ox-LDL) is higher than it is for Ac-LDL. The maximal value for high-affinity association of 125 I-Ox-LDL by Kupffer cells is 2,150 ng apolipoprotein/mg cell protein and for degradation is 780 ng apolipoprotein/mg cell protein.
Mg EGTA (up to 5 raM) was used to determine whether the interaction of Ac-LDL or Ox-LDL with both human liver parenchymal cells and Kupffer cells was calcium dependent. It appears, in agreement with earlier data with rat liver cells, that the cell association of 125 I-Ac-LDL and 12i I-Ox-LDL is not influenced by addition of Mg EGTA (data not shown), indicating that calcium is not needed for the high-affinity interaction of Ac-LDL and Ox-LDL with liver cells.
Processing of Ac-LDL and Ox-LDL
Chloroquine and ammonium chloride were used as lysosomotropic agents to establish the possible involve- I-Ox-LDL by parenchymal cells was also affected by chloroquine, although somewhat less effectively than with Ac-LDL, whereas the degradation of 125 I-Ox-LDL by Kupffer cells also appeared to be mainly lysosomal, based on the concentration-dependent effect of chloroquine.
I-labeled oxidized (Ox) LDL by human parenchymal cells (panels A and C) and Kupffer cells ("panels B and D). Cells were incubated at
Nature of Recognition Sites for Ac-LDL and Ox-LDL on Human Liver Parenchymal and Kupffer Cells
The specificity of the interaction of Ac-LDL and Ox-LDL with parenchymal cells and Kupffer cells was determined by incubating these cell types with 125 I-Ac-LDL or ^I-Ox-LDL at a concentration of 10 /tg/ml with or without increasing amounts of various competitors. The association of 125 I-Ac-LDL with parenchymal cells is competed for by increasing amounts of unlabeled Ac-LDL or Ox-LDL, whereas LDL is ineffective (Figure 4) . (Competition for the association of ^I-Ac-LDL by polyinosinic acid was not determined.) The association of ^I-Ox-LDL with human parenchymal cells is competed for by Ox-LDL, whereas native LDL or polyinosinic acid are much less effective and Ac-LDL does not compete at all. The amount of Ac-LDL or Ox-LDL that was degraded by parenchymal cells when the cells were incubated with 10 /xg/ml 12i I-labeled lipoprotein in the presence of various competitors was too small to give reliable curves. Because 10-100 Mg/ml unlabeled Ac-LDL or Ox-LDL was effective in showing competition although a 720-7,200 molar excess of extracellular human serum albumin was present, these results are, according to the definition of Ho et al, 29 indicative of the presence of specific binding sites on parenchymal cells. With Kupffer cells ( Figure 5 ) the cell association and degradation of ^I-Ac-LDL is inhibited about 70% by unlabeled Ac-LDL or polyinosinic acid. Unlabeled Ox-LDL appears to be slightly less efficient as a competitor than Ac-LDL. Native LDL was relatively ineffective. The cell association and degradation of 125 I-Ox-LDL by Kupffer cells is efficiently inhibited by Ox-LDL itself and by polyinosinic acid. Ac-LDL is clearly less efficient as a competitor than Ox-LDL. The cell association and degradation of 125 I-Ox-LDL is only slightly inhibited by native LDL.
Discussion
In the present work we analyzed the interaction of 125 I-Ac-LDL and 125 I-Ox-LDL with human liver parenchymal cells and human Kupffer cells. Recent studies in rats indicate that Kupffer cells appear to be the main site in the liver for the uptake of Ox-LDL. 6 Because Ox-LDL is considered to be the pathological form of modified LDL, it was suggested that Kupffer cells may form a major protection system against the action of Ox-LDL. 6 Furthermore, in vitro studies with isolated liver cell types (parenchymal, endothelial, and Kupffer cells) provided evidence that in addition to the Ac-LDL receptor, which is concentrated on liver endothelial cells, 8 Kupffer cells contain a scavenger receptor that specifically interacts with Ox-LDL. 6 So far there are no data concerning the role of human liver parenchymal cells and human Kupffer cells in the metabolism of Ac-LDL and Ox-LDL nor on the possible involvement of various scavenger receptors in the uptake of modified LDL. The availability of human parenchymal cells and Kupffer cells enabled us to address these questions for the human situation. Human liver endothelial cells could not be isolated from human liver, probably because of a loss of viable liver endothelial cells, which has been observed to occur when cold ischemic liver material is reperfused with warm oxygenated buffer. 30 The data in this study demonstrate that both human parenchymal cells and Kupffer cells in culture possess calcium-independent, specific recognition sites that recognize Ac-LDL and/or Ox-LDL. Competition experiments indicate that human liver parenchymal cells contain 1) a specific Ac-LDL recognition site, which is partly competed for by Ox-LDL and 2) a specific Ox-LDL recognition site, which is not competed for by Ac-LDL and is hardly by polyinosinic acid. Human Kupffer cells express 1) an Ac-LDL recognition site, which is also blocked by Ox-LDL and polyinosinic acid and 2) an Ox-LDL recognition site, which interacts only partially with Ac-LDL and is completely blocked by polyinosinic acid. These results are comparable with the results that were found for the interaction of Ac-LDL and Ox-LDL with rat liver parenchymal cells and Kupffer cells, 6 indicating that in addition to a scavenger receptor, which interacts with both Ac-LDL and Ox-LDL, a specific Ox-LDL receptor exists on liver cells. It is possible that this receptor is similar to the class III binding sites as defined on basis of the specificity of reconstituted hepatic scavenger receptors. 31 -32 The specific recognition of Ox-LDL by Kupffer cells cannot be explained by aggregation phenomena because we used a relatively low apolipoprotein concentration (200 fig/tnl) for oxidation. Moreover, we subjected Ox-LDL, directly before the incubations, to filtration over a 22-/xm filter; also, complete blockade of the interaction of Ox-LDL with Kupffer cells by polyinosinic acid points to the involvement of scavenger receptors and not bulk-phase endocytosis. To investigate whether lysosomes are involved in the degradation of Ac-LDL and Ox-LDL, chloroquine and ammonium chloride were used. These two unrelated compounds inhibit lysosomal proteolysis by increasing the lysosomal pH. 33 Based on their inhibitory action, it appeared that the uptake of both Ac-LDL and Ox-LDL by parenchymal cells and Kupffer cells was coupled to rysosomal degradation.
There is a dispute about the role of human parenchymal cells in the uptake of modified LDL. Edge demonstrated that Ac-LDL was bound and degraded at 30-50% of the level of that of native LDL. Babaev et al 11 reported that binding, internalization, and degradation of malondialdehyde-treated LDL by cultured human hepatocytes was caused by contamination of the primary cultures by endothelial and Kupffer cells. We observed a specific recognition site for modified LDL in human parenchymal cells, which cannot be due to contamination of the parenchymal cells with nonparenchymal cells, as polyinosinic acid does not compete for the interaction of Ox-LDL with parenchymal cells while polyinosinic acid is a very effective competitor for the interaction of Ac-LDL and Ox-LDL with Kupffer cells. Also, with rat liver cells it has been shown that the interaction of Ac-LDL, Ox-LDL, and Ox-/3-VLDL with endothelial and Kupffer cells is effectively inhibited by polyinosinic acid, whereas with parenchymal cells this interaction is not blocked. Human liver endothelial cells could not be isolated from the human liver, thus, no information about the importance of these cell types for the relative interaction with Ac-LDL and Ox-LDL could be obtained. From in vivo and in vitro studies with rats it has been shown that rat liver endothelial cells account for 52% of the total uptake of Ac-LDL and for 36% of the total uptake of Ox-LDL. 6 Recent studies in which human liver tissue blocks were perfused in vitro with l,l'-dioctadecyl-333'»3'-tetramethyl indocarbocyanine perchlorate-labeled Ac-LDL provide evidence that in the human liver also, Ac-LDL is mainly taken up by liver endothelial cells.
The capacity of human Kupffer cells for cell association and degradation of Ac-LDL and Ox-LDL is considerably higher than that of parenchymal cells (respectively, 4.8-and 4.9-fold per milligram of cell protein) for which, in addition to a scavenger receptor, which interacts with both Ac-LDL and Ox-LDL, a specific Ox-LDL receptor is responsible. It appears that the recognition sites for Ac-LDL and Ox-LDL on human parenchymal and human Kupffer cells exert similar properties as those on rat liver cells. Earlier, we demonstrated that human Kupffer cells also have a higher capacity than do parenchymal cells to catabolize native LDL.
14 Together, these data indicate that Kupffer cells may contribute significantly to the regulation of the level of (modified) LDL in the human situation and thus in the protection against the development of atherosclerosis.
Several lines of evidence, such as the occurrence of autoantibodies against oxidized LDL in human sera 3 * and the prevention of the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits by probucol, 37 -38 indicate that Ox-LDL is the pathophysiologicalry occurring form of modified LDL. The presence of a specific Ox-LDL recognition site on human liver parenchymal cells and especially on human Kupffer cells may form a major protection in humans against the pathological action of Ox-LDL in the blood compartment.
